Skip to Main content Skip to Navigation
Journal articles

Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency

Abstract : Both innate and adaptive lymphocytes have critical roles in mucosal defense that contain commensal microbial communities and protect against pathogen invasion. Here we characterize mucosal immunity in human severe combined immunodeficiency (SCID) patients receiving hematopoietic stem cell transplantation (HSCT) with or without myeloablation. We confirmed that pre-transplant conditioning impacted on innate (NK, ILC) and adaptive (B and T cells) lymphocyte reconstitution in these SCID patients and now demonstrate that this further extends to generation of Th2 and Tc2 cells. Using an integrated approach to assess nasopharyngeal immunity, we identify a local mucosal defect in type 2 cytokines, mucus production and a selective local IgA deficiency in HSCT-treated SCID patients with genetic defects in IL2RG/GC or JAK3. These patients have a reduction in IgA-coated nasopharyngeal bacteria and exhibit microbial dysbiosis with increased pathobiont carriage. Interestingly, IVIG replacement therapy can partially normalize nasopharyngeal Ig profiles and restore microbial communities in GC/JAK3 patients. Together, our results suggest a potential non-redundant role for type 2 immunity and/or of local IgA antibody production in the maintenance of nasopharyngeal microbial homeostasis and mucosal barrier function.
Document type :
Journal articles
Complete list of metadata
Contributor : James Di Santo Connect in order to contact the contributor
Submitted on : Monday, March 7, 2022 - 11:37:28 AM
Last modification on : Friday, August 5, 2022 - 11:56:05 AM
Long-term archiving on: : Wednesday, June 8, 2022 - 7:04:15 PM


Distributed under a Creative Commons Attribution 4.0 International License




Pedro Goncalves, Jean-Marc Doisne, Toshiki Eri, Bruno Charbit, Vincent Bondet, et al.. Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency. Blood, American Society of Hematology, 2022, pp.2021014654. ⟨10.1182/blood.2021014654⟩. ⟨pasteur-03599568⟩



Record views


Files downloads